Suchergebnisse - "Vanella, Vito"

PubPharm (10)

1

Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors

enthalten in: Frontiers in immunology | 2022

von Cristiani, C. | Capone, M. | Garofalo, C. | +10

2

PD-L1+ neutrophils as novel biomarkers for stage IV melanoma patients treated with nivolumab

enthalten in: Frontiers in immunology | 2022

von Cristinziano, L. | Modestino, L. | Capone, M. | +11

3

Clinical Categorization Algorithm (CLICAL) and Machine Learning Approach (SRF-CLICAL) to Predict Clinical Benefit to Immunotherapy in Metastatic Melanoma Patients : Real-World Evidence from the Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy

enthalten in: Cancers | 2021

von Madonna, G. | Masucci, G. | Capone, M. | +15

4

Epigenetic Regulation in Melanoma : Facts and Hopes

enthalten in: Cells | 2021

von Giunta, E. | Arrichiello, G. | Curvietto, M. | +17

5

Impact of COVID-19 outbreak on cancer immunotherapy in Italy : a survey of young oncologists

enthalten in: Journal for immunotherapy of cancer | 2020

von Ottaviano, M. | Curvietto, M. | Rescigno, P. | +93

6

Melanoma : Prognostic Factors and Factors Predictive of Response to Therapy

enthalten in: Current medicinal chemistry | 2020

von Strudel, M. | Festino, L. | Vanella, V. | +3

7

ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma : Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin

enthalten in: Cancers | 2019

von Ruggiero, C. | Malpicci, D. | Fattore, L. | +10

8

Encorafenib in combination with binimetinib for unresectable or metastatic melanoma with BRAF mutations

enthalten in: Expert review of clinical pharmacology | 2019

von Trojaniello, C. | Festino, L. | Vanella, V. | +1

ErratumIn: Expert Rev Clin Pharmacol. 2021 Jan;14(1):i. - PMID 32501733

9

Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma

enthalten in: Oncoimmunology | 2017

von Simeone, E. | Grimaldi, A. | Festino, L. | +8

10

PD-L1 inhibitors in the pipeline : Promise and progress

enthalten in: Oncoimmunology | 2017

von Vanella, V. | Festino, L. | Strudel, M. | +3

1
[1]